Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Almac and VTU Technology announced today their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for half-life extension of proteins.
read more
Almac today announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. The company has established regional hubs in Singapore ...
read more
Almac are pleased to announce the launch of their novel “Direct to Patient” shipping service for clinical trials recognising the shift in market trends to introduce as many efficiencies as possible into the management of clinical trials and the ...
read more
Almac is pleased to announce the Qualified Person (QP) Facilitation Programme; a value-add enhancement to Almac’s current suite of QP services. Offered to global clients importing investigational medicinal products (IMP) into the European Union for ...
read more
Almac is pleased to announce the launch of a mobile optimised version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready ...
read more
Tuesday, September 24, 2013
Almac today announced the launch of SupplyTraQ™, a web-based drug accountability and reconciliation tool that improves clinical trial drug supply management and simplifies post-trial administration. Compatible with IXRS®, the company’s industry-...
read more
Tuesday, September 10, 2013
Almac today announced they are now offering a Tumor Profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor™ panel as part of their biomarker discovery, development and delivery solutions.
read more
Thursday, August 01, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. ...
read more
Wednesday, April 04, 2012
The Almac Group announced today that its Clinical Technologies Business Unit has made significant progress in advancing its Six Sigma-led quality and productivity initiatives. The program began with the goals of increasing quality and productivity by...
read more
Wednesday, February 29, 2012
Almac has over 20 years of experience in the management of clinical trial supplies and IXRS® technology. Our clinical supplies management and integrated Interactive Voice and Web Response (IVR/IWR) technology services have been deployed in over 7,700...
read more
Thursday, September 05, 2013
In a dual announcement Almac Discovery Ltd and Queen’s University, Belfast (QUB) have revealed the launch of a formal working partnership between Almac and the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s, and a significant ...
read more
Almac will be hosting a series of complementary ‘lunch and learn’ style workshops across Europe and the US this spring tailored towards clinical trial / outsourcing professionals from Pharmaceutical and Biotech companies.
read more
Wednesday, March 20, 2013
The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.” The day-long, interactive workshops are intended for clinical trial...
read more
Thursday, August 29, 2013
Amgen and Onyx Pharmaceuticals, Inc. today announced that their Boards of Directors have unanimously approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 ...
read more
AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions ...
read more